Anti-Diabetic Activity of Viscum Album (Guava Mistletoe) in Alloxan-Induced Diabetic Rats
Anti-Diabetic Activity of Viscum Album (Guava Mistletoe) in Alloxan-Induced Diabetic Rats
Anti-Diabetic Activity of Viscum Album (Guava Mistletoe) in Alloxan-Induced Diabetic Rats
ISSN: 2319-7064
ResearchGate Impact Factor (2018): 0.28 | SJIF (2018): 7.426
Abstract: This study was carried out to investigate the antidiabetic activity of aqueous leaf extract of Viscum album (Guava mistletoe)
and compare its antidiabetic efficacy against the oral antidiabetic drug metformin, using alloxan-induced rat models. Phytochemicals
detected includes alkaloids, phenols, flavonoids, tannins, anthraquinones, cardiac glycosides and terpenoids. Biochemical analysis
showed a dose-dependent significant decrease (p<0.05) in the levels of serum glucose in the rats when treated with Viscum album leaf
extract after the induction of diabetic. This observation was vivid when Viscum album treated groups were compared to the diabetic
control and metformin- treated groups. Similarly, there was a significant decrease in the levels of total cholesterol, triglycerides, and
low density lipoproteins that were hitherto elevated before treatment with the leaf extract. A corresponding significant increase in the
levels of high density lipoproteins was observed when compared with the diabetic control group. The plant extract significantly (p<0.05)
lowered the serum activities of marker enzymes: Alanine and Aspartate aminotransferases. Similarly, a significant decrease (p<0.05) in
creatinine and urea levels was observed in the extract and metformin treated groups when compared to the diabetic control group. In
addition, the plant extract attenuated the weight loss observed in diabetic control group. Aqueous leaf extract of Viscum album exhibited
high antidiabetic activity which compares fairly well with metformin and very effective in ameliorating other complications associated
with diabetic mellitus.
The use of orthodox drugs as oral hypoglycaemic agents Gestational diabetes mellitus (GDM) resembles type 2
such as sulphonyl ureas, biguanides, alpha glucosidase diabetes in several respects, involving a combination of
inhibitors and insulin result to severe hypoglycaemia and relatively inadequate insulin secretion and responsiveness. It
other complications in patients prompting the desire for occurs in about 2%–5% of all pregnancies and may improve
Volume 8 Issue 4, April 2019
www.ijsr.net
Licensed Under Creative Commons Attribution CC BY
Paper ID: 8021901 10.21275/8021901 208
International Journal of Science and Research (IJSR)
ISSN: 2319-7064
ResearchGate Impact Factor (2018): 0.28 | SJIF (2018): 7.426
or disappear after delivery (CDC, 2012). It is characterized Qualitative phytochemicals screening was carried out to
by carbohydrate intolerance resulting in hyperglycaemia of detect the presence of tannins, flavonoids, saponins,
variable severity with onset or first recognition during alkaloids, glycosides, steroids, terpenoids, quinones,
pregnancy. It does not exclude the possibility that the anthraquinones and phlobatannins as described by Trease
glucose intolerance may antedate pregnancy but has been and Evans (1985) and Sofowora (1993).
previously unrecognized. The definition applies irrespective
of whether or not insulin is used for treatment or the Twenty five (25) male albino Wistar rats weighing
condition persists after pregnancy (Betterle, 2003). approximately 100-120g that were used in this experimental
study were obtained from the animal house of the National
In the early part of pregnancy (e.g. first trimester and first Veterinary Research Institute (NVRI) Vom, Plateau State.
half of second trimester) fasting and postprandial glucose They were kept under standard laboratory conditions with
concentrations are normally lower than in normal, non– adequate access to food and water in the laboratory unit of
pregnant women. Elevated fasting or postprandial plasma the Biochemistry department of the university in well
glucose levels at this time in pregnancy may well reflect the ventilated cages. The rats were randomly divided into five
presence of diabetes which has antedated pregnancy, but equal groups containing 5 rats each and were treated
criteria for designating abnormally high glucose accordingly as shown below:
concentrations at this time have not yet been established.
Induction of Diabetes Mellitus
Alloxan The method of Osinubi et al., (2006) was used to induce
Alloxan (2, 4, 5, 6-tetraoxypyrimidine; 2, 4, 5, 6- diabetes in the rats. 80mg/kg body weight of alloxan was
pyrimidinetetrone) was originally isolated in 1818 by administered intraperitoneally to the experimental rats after
Brugnatelli and named in 1838 by Wöhler and Liebig. overnight fast (access to water only). Diabetes mellitus was
"Alloxan" is coined from an amalgamation of the words confirmed using glucose strip and only rats with serum
"allantoin" and oxalic acid. Alloxan is a strong oxidizing glucose levels above 250mg/dl after seven days were used
agent forming a hemiacetal with its reduced reaction product for the experiment.
dialuric acid (in which a Carbonyl group is reduced to a Group 1: Were administered normal diet to serve as normal
Hydroxyl group which is called alloxantin. control.
Group 2: Were administered alloxan (80mg/kg body
Mechanism of Action weight) in addition to normal diet to serve as diabetic
Alloxan is a toxic glucose analogue, which selectively control.
destroys insulin-producing cells in the pancreas (that is beta Group 3: Diabetic rats were administered 200mg/kg body
cells) when administered to rodents and many other animal weight of Viscum album aqueous extract for 21 days.
species. This causes an insulin-dependent diabetes mellitus Group 4: Diabetic rats were administered 400mg/kg body
(called "Alloxan Diabetes") in these animals, with weight of Viscum album aqueous extract for 21 days.
characteristics similar to type I diabetes in humans. Alloxan Group 5: Diabetic rats were administered 1.6mg/kg body
is selectively toxic to insulin-producing pancreatic beta cells weight of metformin orally per day to serve as drug control.
because it preferentially accumulates in beta cells through Glucose levels were measured at seven days interval and
uptake via the GLUT2 glucose transporter. Alloxan, in the recorded accordingly before the rats were finally sacrificed
presence of intracellular thiols, generates reactive oxygen at the end of 21 days of the experimental period.
species (ROS) in a cyclic reaction with its reduction product,
dialuric acid. The beta cell toxic action of alloxan is initiated Determination of Body Weight
by free radicals formed in this redox reaction. A study The body weight of each rat in each group at three days
suggests that alloxan does not cause diabetes in humans interval for the period of the experiment was obtained using
while other studies report a significant difference in alloxan a weighing balance. The average weight of each group was
plasma levels in children with and without diabetes Type I taken and recorded carefully.
(Dinz et al., 2008).
Biochemical Analysis
Collection of Plant Material At the end of the experimental period, the animals were
Fresh leaves of Viscum album on guava plant was collected anaesthetised in chloroform vapour, dissected and blood
in Sangere, Girei Local Government Area of Adamawa samples collected by cardiac puncture into clean sample
State. The leaf sample was identified and authenticated in bottles. The blood was allowed to clot for few minutes.
the department of Plant science, Modibbo Adama University Serum was obtained by centrifugation at 3,000 rpm for five
of Technology, Yola. minutes using a bench top centrifuge.
The leaves were cleaned and air-dried at room temperature. Serum glucose concentration determination was carried out
The dried leaves were ground into powder and kept in air using the methods describe by Barham and Trinder, (1972).
tight bottle for further analysis. About 200g of the fine Principle of the method:
powder was soaked in 1.5 litres of boiling water with stirring
for 4 hours. The mixture was filtered and the filtrate Glucose is determined after enzymatic oxidation in the
concentrated in a rotary evaporator. This was preserved for presence of glucose oxidase. The hydrogen peroxide formed
further use. reacts, under catalysis of peroxidase, with phenol and 4-
aminophenazone to form a red-violet quinoneimine dye as
indicator.
Volume 8 Issue 4, April 2019
www.ijsr.net
Licensed Under Creative Commons Attribution CC BY
Paper ID: 8021901 10.21275/8021901 209
International Journal of Science and Research (IJSR)
ISSN: 2319-7064
ResearchGate Impact Factor (2018): 0.28 | SJIF (2018): 7.426
Total serum cholesterol concentration determination was dehydrating agent. The final bluish green coloured obtained
carried out using the method described by Trinder, (1969). is read at 570nm.
Cholesterol reacts with concentrated acids as a typical
alcohol to produce coloured substances. In this method,
acetic acid and acetic anhydride are used as solvents and
dehydrating reagents, conc. H2SO4 is employed as a
Determination of triglyceride was carried out according to and Mg2+ ions. A coloured product which absorb well at
the method describe by Trinder (1969) and Nagele et al., 505nm is formed from hydrogen peroxide, 4-
(1984). aminoantipyrine and phenol derivative in the presence of the
peroxidase.
Principle of the method:
Triglyceride in the sample is hydrolysed to glycerol and
fatty acids by lipoprotein lipase. Glycerine is then
phosphorylated by glycerol kinase in the presence of ATP
The method of Reitman and Frankel (1957) was used for the 2. Results and Discussion
determination of aspartate and alanine amintransferases.
Principle Qualitative phytochemicals screening of the leaf extract of
V. album revealed the presence of alkaloids, phenols,
The enzyme, GPT catalyzes the formation of pyruvate and flavonoids, tannins, anthraquinones, cardiac glycosides and
glutamate from the reaction between alanine and terpenoids. Saponins and steroids were not detected. The
ketoglutarate. The pyruvate formed now reacts with 2, 4- summary of the result is shown in Table I:
Dinitrophenylhydrazine to form 2, 4-
Dinitrophenylhydrazone to yield the red colour and the
activity of ALT is dependent on the intensity of the colour.
Figure I: Effect of V. album leaf extract on the Body Weight of alloxan-induced diabetic rats (g)
The induction of diabetes by alloxan (150mg/kgbwt) showed weekly fasting glucose level was observed with the leaf
a marked rise in fasting blood glucose level in diabetic extract and metformin treated groups when compared to the
control as compared to normal control rats. However, at the diabetic control. A summary of the results is presented in
end of the 21 days long treatment, a significant decrease in Table II below:
Table II: Effects of V. album aqueous leaf extract on Weekly Blood Glucose level
Group Fasting Blood Glucose level (mg/dl)
INITIAL WEEK ONE WEEK TWO WEEK THREE
Normal Control 57.60±6.73 72.00±4.93 55.80±9.18 54.25±1.90
Diabetic control 273.60±11.93* 349.80±28.20* 453.60±6.73* 525.60±17.12*
200mg/kgbwt 280.80±22.48* 230.40±25.07*β 205.20±13.77*β 197.71±2.57*β
400mg/kgbwt 309.60±43.87* 217.80±7.20*β 180.00±5.69*β 155.41±2.65*β
Drug control (Metformin) 295.20±23.88* 203.40±11.94*β 226.80±81.02*β 143.82±0.64*β
Results are expressed asMean±Standard error of mean (S.E.M); n=5
*
Showed a significant increase compared with normal control at P<0.05
β
Showed a significant decrease compared with diabetic control at P< 0.05
Total cholesterol, triglyceride and low density lipoprotein with the extract and metformin significantly attenuated
(LDL) levels were found to be significantly (P<0.05) (P<0.05) the elevated total cholesterol, triglyceride and LDL
increased and significant decrease in high density levels and increased the HDL levels in comparison with the
lipoprotein (HDL)-cholesterol levels in the diabetic control diabetic control as shown in Table III below:
group in comparison with the normal control. Treatment
Table III: Effects of V. album extract on serum Lipid Profiles of alloxan-induced diabetic rats
Group Serum Lipid Profile
Total cholesterol Triglycerides High Density Lipoprotein Low Density Lipoprotein
(mg/dl) (mg/dl) (mg/dl) (mg/dl)
Normal Control 98.94±1.45 70.32±0.30 53.70±1.04 31.17±0.44
Diabetic control 192.31±1.57* 153.09±1.53* 41.89±0.32 80.84±0.94*
200mg/kgbwt 141.46±2.49*β 99.00±1.23*β 61.33±0.76 *α 60.23±3.11*β
400mg/kgbwt 122.24±2.49*β 81.62±1.46*β 63.30±0.81*α 42.61±1.50*β
Drug control (Metformin) 109.88±0.89*β 73.95±2.15*β 64.18±0.00 *α 30.67±0.53β
Results are expressed asMean± Standard error of mean (S.E.M); n=3
*
Showed a significant increase compared with normal control at P< 0.05